| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ratnam S et al. | Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. | 2003 | N. Engl. J. Med. | pmid:14626257 |
| Kida Y | Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. | 2003 | N. Engl. J. Med. | pmid:14626256 |
| Drüeke TB and McCarron DA | Paricalcitol as compared with calcitriol in patients undergoing hemodialysis. | 2003 | N. Engl. J. Med. | pmid:12890849 |
| Martin CJ and Reams SM | The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey. | 2003 | J Ren Nutr | pmid:12671837 |
| Schroeder NJ et al. | Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells. | 2003 | Nephron Physiol | pmid:12972708 |
| Molnár I et al. | 19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines. | 2003 | J. Cancer Res. Clin. Oncol. | pmid:12618899 |
| Kumagai T et al. | Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. | 2003 | J. Natl. Cancer Inst. | pmid:12813173 |
| Slatopolsky E et al. | Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. | 2003 | Kidney Int. | pmid:12753289 |
| Sprague SM et al. | Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. | 2003 | Kidney Int. | pmid:12631365 |
| Cardús A et al. | [Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells]. | 2003 | Nefrologia | pmid:12778867 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.